ASCL1 regulates super‐enhancer‐associated miRNAs to define molecular subtypes of small cell lung cancer

Author:

Miyakawa Kazuko1,Miyashita Naoya1ORCID,Horie Masafumi2,Terasaki Yasuhiro3,Tanaka Hidenori4,Urushiyama Hirokazu1,Fukuda Kensuke1ORCID,Okabe Yugo1,Ishii Takashi15,Kuwahara Naomi3,Suzuki Hiroshi I.67,Nagase Takahide1,Saito Akira1ORCID

Affiliation:

1. Department of Respiratory Medicine, Graduate School of Medicine The University of Tokyo Tokyo Japan

2. Department of Molecular and Cellular Pathology, Graduate School of Medical Sciences Kanazawa University Kanazawa Japan

3. Department of Analytic Human Pathology, Nippon Medical School Tokyo Japan

4. Department of Otorhinolaryngology‐Head and Neck Surgery, Graduate School of Medicine Osaka University Osaka Japan

5. Division for Health Service Promotion The University of Tokyo Tokyo Japan

6. Division of Molecular Oncology, Center for Neurological Diseases and Cancer Nagoya University Graduate School of Medicine Nagoya Japan

7. Institute for Glyco‐core Research (iGCORE) Nagoya University Nagoya Japan

Funder

Japan Society for the Promotion of Science

Takeda Science Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3